| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.45 | 0.03 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |